
Edison Scientific builds and deploys AI scientist agents to accelerate science and the development of new medicines. We are an ambitious team run by scientists and engineers from leading institutions across biology, physics, chemistry, and AI.
We’re looking for a DMPK Subject Matter Expert to join our Forward Deployed team, working onsite with pharma and biotech partners alongside our engineers. Your job: ensure our AI agents produce DMPK and PK/PD outputs that are scientifically rigorous, decision ready, and aligned with how drug development teams actually advance compounds.
You’ll evaluate agent performance on PK analysis, ADME interpretation, human dose projection, and IND DMPK report sections. You’ll work with our partners’ DMPK, clinical pharmacology, and development teams to identify where AI can streamline their workflows. And you’ll bring real-world translational experience to everything our platform generates. You’re the person who knows whether an AI-generated dose projection or DMPK package would hold up to internal governance and regulatory review.
This is embedded, partner-facing work. You’ll build relationships with DMPK and development leaders, understand their program constraints and regulatory requirements, and feed that knowledge back to our AI team. Over time, you’ll define the scientific approaches that train and evolve our agents, shaping how DMPK is practiced across the AI industry.
$220k- $275k
We're a fast-moving, mission-driven culture where smart people do their best work and actually enjoy doing it. We also offer full-time employees the following:
Edison Scientific is an equal opportunity employer. We do not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other protected characteristic under applicable law.

Edison Scientific is building the AI platform for scientific research and development. Kosmos, our AI scientist, collaborates with teams across the full R&D lifecycle, leveraging proprietary data and organizational context to help navigate complex scientific decisions and accelerate timelines from discovery to FDA approval.
We believe the full gains from AI in science will only be realized when AI systems are integrated across the entire research and development stack, continuously learning from the evolving scientific context inside an organization. With Edison Scientific, scientists and researchers remain at the center of scientific progress, using AI to amplify their expertise and accelerate discovery at unprecedented speed.
Edison is a scientist-led company that was spun out of the nonprofit research lab FutureHouse in 2025, backed by $70M from Spark Capital, Triatomic Capital, Susa Ventures, Pillar Ventures, among other investors.